| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |